메뉴 건너뛰기




Volumn 42, Issue 4, 2008, Pages 271-274

Lack of utility of chimerism studies obtained 2-3 months after myeloablative hematopoietic cell transplantation for ALL

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

EID: 51049096557     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.155     Document Type: Article
Times cited : (21)

References (12)
  • 1
    • 0034769445 scopus 로고    scopus 로고
    • Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a workshop at the 2001 Tandem Meetings (Review)
    • Antin JH, Childs R, Filipovich AH, Giralt S, Mackinnon S, Spitzer T et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a workshop at the 2001 Tandem Meetings (Review). Biol Blood Marrow Transplant 2001; 7: 473-485.
    • (2001) Biol Blood Marrow Transplant , vol.7 , pp. 473-485
    • Antin, J.H.1    Childs, R.2    Filipovich, A.H.3    Giralt, S.4    Mackinnon, S.5    Spitzer, T.6
  • 2
    • 33750104824 scopus 로고    scopus 로고
    • Chimerism and outcomes after allogeneic hematopoietic cell transplantation following non-myeloablative conditioning (Review)
    • Baron F, Sandmaier BM. Chimerism and outcomes after allogeneic hematopoietic cell transplantation following non-myeloablative conditioning (Review). Leukemia 2006; 20: 1690-1700.
    • (2006) Leukemia , vol.20 , pp. 1690-1700
    • Baron, F.1    Sandmaier, B.M.2
  • 3
    • 0032533228 scopus 로고    scopus 로고
    • Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient
    • Petersdorf EW, Gooley TA, Anasetti C, Martin PJ, Smith AG, Mickelson EM et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998; 92: 3515-3520.
    • (1998) Blood , vol.92 , pp. 3515-3520
    • Petersdorf, E.W.1    Gooley, T.A.2    Anasetti, C.3    Martin, P.J.4    Smith, A.G.5    Mickelson, E.M.6
  • 4
    • 0024510510 scopus 로고
    • Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: Long-term follow-up of a controlled trial
    • Storb R, Deeg HJ, Pepe M, Appelbaum FR, Anasetti C, Beatty P et al. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: Long-term follow-up of a controlled trial. Blood 1989; 73: 1729-1734.
    • (1989) Blood , vol.73 , pp. 1729-1734
    • Storb, R.1    Deeg, H.J.2    Pepe, M.3    Appelbaum, F.R.4    Anasetti, C.5    Beatty, P.6
  • 5
    • 0027161889 scopus 로고
    • Fluorescence in situ hybridization with X and Y chromosome probes for cytogenetic studies on bone marrow cells after opposite sex transplantation
    • Dewald GW, Schad CR, Christensen ER, Law ME, Zinsmeister AR, Stalboerger PG et al. Fluorescence in situ hybridization with X and Y chromosome probes for cytogenetic studies on bone marrow cells after opposite sex transplantation. Bone Marrow Transplant 1993; 12 149-154.
    • (1993) Bone Marrow Transplant , vol.12 , pp. 149-154
    • Dewald, G.W.1    Schad, C.R.2    Christensen, E.R.3    Law, M.E.4    Zinsmeister, A.R.5    Stalboerger, P.G.6
  • 6
    • 0028939206 scopus 로고
    • Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers
    • Scharf SJ, Smith AG, Hansen JA, McFarland C, Erlich HA. Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers. Blood 1995; 85: 1954-1963.
    • (1995) Blood , vol.85 , pp. 1954-1963
    • Scharf, S.J.1    Smith, A.G.2    Hansen, J.A.3    McFarland, C.4    Erlich, H.A.5
  • 7
    • 0033301382 scopus 로고    scopus 로고
    • Analysis of amplified variable number tandem repeat loci for evaluation of engraftment after hematopoietic stem cell transplantation
    • Smith AG, Martin PJ. Analysis of amplified variable number tandem repeat loci for evaluation of engraftment after hematopoietic stem cell transplantation. Rev Immunogenet 1999; 1: 255-264.
    • (1999) Rev Immunogenet , vol.1 , pp. 255-264
    • Smith, A.G.1    Martin, P.J.2
  • 8
    • 17744376761 scopus 로고    scopus 로고
    • Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers
    • Thiede C, Bornhauser M, Oelschlagel U, Brendel C, Leo R, Daxberger H et al. Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers. Leukemia 2001; 15: 293-302.
    • (2001) Leukemia , vol.15 , pp. 293-302
    • Thiede, C.1    Bornhauser, M.2    Oelschlagel, U.3    Brendel, C.4    Leo, R.5    Daxberger, H.6
  • 9
    • 33845382806 scopus 로고
    • Nonparametric estimation from incomplete observations
    • Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2
  • 10
    • 2442704411 scopus 로고    scopus 로고
    • Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: Possible role for pre-emptive immunotherapy?
    • Bader P, Kreyenberg H, Hoelle W, Dueckers G, Handgretinger R, Lang R et al. Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: Possible role for pre-emptive immunotherapy? J Clin Oncol 2004; 22: 1696-1705.
    • (2004) J Clin Oncol , vol.22 , pp. 1696-1705
    • Bader, P.1    Kreyenberg, H.2    Hoelle, W.3    Dueckers, G.4    Handgretinger, R.5    Lang, R.6
  • 11
    • 10044234257 scopus 로고    scopus 로고
    • Documentation of engraftment and characterization of chimerism following hematopoietic cell transplantation
    • Blume KG, Forman SJ, Appelbaum FR eds, Blackwell: Oxford, UK
    • Bryant E, Martin PJ. Documentation of engraftment and characterization of chimerism following hematopoietic cell transplantation. In: Blume KG, Forman SJ, Appelbaum FR (eds). Thomas' Hematopoietic Cell Transplantation. Blackwell: Oxford, UK, 2004, pp 234-243.
    • (2004) Thomas' Hematopoietic Cell Transplantation , pp. 234-243
    • Bryant, E.1    Martin, P.J.2
  • 12
    • 1542368037 scopus 로고    scopus 로고
    • Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia
    • Doney K, Hägglund H, Leisenring W, Chauncey T, Appelbaum FR, Storb R. Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia. Biol Blood Marrow Transplant 2003; 9: 472-481.
    • (2003) Biol Blood Marrow Transplant , vol.9 , pp. 472-481
    • Doney, K.1    Hägglund, H.2    Leisenring, W.3    Chauncey, T.4    Appelbaum, F.R.5    Storb, R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.